Copyright
©The Author(s) 2021.
World J Crit Care Med. Jan 9, 2021; 10(1): 12-21
Published online Jan 9, 2021. doi: 10.5492/wjccm.v10.i1.12
Published online Jan 9, 2021. doi: 10.5492/wjccm.v10.i1.12
Table 1 Description of the studied group
| Variable | n | Minimum | Maximum | mean ± SD |
| Age | 399 | 18 | 79 | 51.9 ± 11.3 |
| BMI (kg/m2) | 399 | 18.8 | 43.7 | 25.1 ± 7.1 |
| Creatinine (μmol/L) | 397 | 54.9 | 378.1 | 99.8 ± 55.8 |
| EF% | 388 | 18 | 65 | 45.8 ± 8.9 |
| Additive Euro score | 398 | 0 | 19 | 4.6 ± 3.1 |
| CPB time (min) | 393 | 0 | 377 | 118.1 ± 46.9 |
| ACC time (min) | 392 | 0 | 188 | 86.1 ± 38.7 |
| Anesthesia time (min) | 398 | 220 | 630 | 295.7 ± 71.2 |
| VIS | 398 | 0 | 29 | 6 ± 2.1 |
| LOSICU (h) | 397 | 26 | 320 | 65.9 ± 46.1 |
| LOV (min) | 397 | 190 | 17300 | 432 ± 65 |
| LOShosp (d) | 394 | 6 | 245 | 28.1 ± 12.9 |
Table 2 Demographic differences between both groups
| Variable | Group I (LMS), 75 (%) | Group II (no LMS), 324 (%) | P value |
| Age | 58.3 ± 11.8 | 55.19 ± 9.7 | 0.06 |
| Gender (male) | 62 (82.6) | 264 (81.4) | 0.34 |
| Diabetes | 39 (52) | 144 (44.4) | 0.05 |
| Hypertension | 32 (42.6) | 144 (44.4) | 0.13 |
| Euro score | 5.8 ± 3.9 | 5.0 ± 3.6 | 0.6 |
| BMI | 30.1 ± 6.3 | 27.9 ± 5.8 | 0.6 |
| EF < 40 | 24 (32) | 86 (26.5) | 0.07 |
| IABP | 28 (37.3) | 80 (24.6) | 0.05 |
| Elective surgery | 45 (60) | 224 (66.6) | 0.5 |
| Basal creatinine (μmol/L) | 98.7 ± 46.5 | 94.7 ± 43.1 | 0.6 |
Table 3 Main differences in both studied groups
| Variable | Group I (LMS), 75 (%) | Group II (no LMS), 324 (%) | P value |
| Inotrops | |||
| Dopamine, mean dose (μg/kg/min), mean ± SD | 9 (12), 6.50 ± 3.10 | 31 (9.6), 7.23 ± 15.2 | 0.5, 0.34 |
| Adrenaline, mean dose (μg/kg/min), mean ± SD | 6 (8), 0.06 ± 0.01 | 27 (8.3), 0.05 ± 0.009 | 0.6, 0.8 |
| Noradrenline, mean dose (μg/kg/min), mean ± SD | 12 (16), 0.08 ± 0.01 | 43 (13.2), 0.07 ± 0.008 | 0.4, 0.7 |
| Dobutamine, mean dose (μg/kg/min), mean ± SD | 4 (5.3), 4.5 ± 1.4 | 11 (3.3), 3.9 ± 1.1 | 0.06, 0.09 |
| Milrinone, mean dose (μg/kg/min), mean ± SD | 3 (4), 0.56 ± 0.05 | 7 (2.1), 0.6 ± 0.04 | 0.9, 0.4 |
| Intraoperative parameters | |||
| CPB time (min) | 139 ± 43 | 125 ± 69.6 | 0.6 |
| ACC time (min) | 87.1 ± 34 | 79.3 ± 30.1 | 0.9 |
| Anesthesia time (min) | 6.6 ± 1.4 | 6.5 ± 1.8 | 0.9 |
| Grafts | 3.1 ± 0.8 | 3.4 ± 1.01 | 0.7 |
| Postoperative parameters | |||
| LOV (min) | 384.1 ± 123 | 375.1 ± 119 | 0.8 |
| LOSICU (h) | 65.9 ± 46.1 | 63.4 ± 43.9 | 0.6 |
| LOShosp (d) | 16.1 ± 4.2 | 14.7 ± 3.7 | 0.6 |
| VIS | 6.4 ± 2.6 | 6.1 ± 2.2 | 0.4 |
| Post-operative outcome | |||
| POAF | 12 (16) | 39 (12) | 0.06 |
| AKI | 20 (26.7) | 75 (23.1) | 0.09 |
| In-hospital-mortality | 2 (2.7) | 7 (2.1) | 0.8 |
| VAP | 1 (1.3) | 5 (1.5) | 0.7 |
| VA-ECMO | 2 (2.7) | 4 (1.2) | 0.08 |
| Re-admission ICU | 2 (2.7) | 8 (2.5) | 0.8 |
| Re-exploration | 6 (8) | 26 (8.6) | 0.5 |
| PMI | 3 (4) | 11 (3.3) | 0.4 |
- Citation: Omar AS, Hanoura S, Shouman Y, Sivadasan PC, Sudarsanan S, Osman H, Pattath AR, Singh R, AlKhulaifi A. Intensive care outcome of left main stem disease surgery: A single center three years’ experience. World J Crit Care Med 2021; 10(1): 12-21
- URL: https://www.wjgnet.com/2220-3141/full/v10/i1/12.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v10.i1.12
